GateHouse Media Inc., doing business as GateHouse Media New England, by its attorneys, Hiscock & Barclay, LLP, on Dec. 22, 2008, filed a suit against The New York Times Co.,…
Eli Lilly and Co. continues to pursue lawsuits against Novopharm Ltd., Pharmascience, Sandoz Inc., Nu-Pharm, and Genpharm for the infringement of its Zyprexa(R) patents in Canada.
In 2005, Apotex Inc. and…
Eli Lilly and Co.’s Gemzar(R) patents infringement lawsuit against Sicor Pharmaceuticals, Inc. has been scheduled for trial in July 2009.
Sicor Pharmaceuticals, Inc., Mayne Pharma (USA) Inc., and Sun Pharmaceutical Industries…
Eli Lilly and Co. is reviewing the allegations by generic drug manufacturers that the Company’s patents that relate to the Cymbalta(R) product are either invalid or not infringed.
The Company has…
International Game Technology is opposing Aristocrat Technologies Australia PTY Ltd.’s petition for certiorari in the U.S. Supreme Court, according to its latest quarterly report on Form 10-Q dated Nov. 26,…
A Jan. 16, 2009 claim construction hearing has been set for the remaining patents at issue in International Game Technology’s infringement suit against Bally Technologies Inc., Bally Gaming Int’l Inc.,…
Eli Lilly and Co. continues to pursue main infringement actions against all generic companies marketing generic olanzapine products in Germany, according to the Company’s latest Quarterly Reports filed with the…
Eli Lilly and Co. is pursuing litigation against Teva Parenteral Medicines, Inc. and APP Pharmaceuticals, LLC over the infringement of the Alimta(R) compound patent in the U.S. District Court for…
International Game Technology’s request for a rehearing in Aristocrat Technologies Australia PTY Ltd. and Aristocrat Technologies Inc.’s patent infringement suit was denied on Nov. 17, 2008.
Aristocrat sued the Company on…
Eli Lilly and Co.’s appeal from the September 2007 final judgment indicating that Ariad Pharmaceuticals Inc.’s claims are patentable, valid, and enforceable remains pending.
In June 2002, Ariad Pharmaceuticals Inc., the…